BioHealth News Archive
Army teams with Johns Hopkins to advance materials research | Article | The United States Army
ABERDEEN PROVING GROUND, Md. -- The U.S. Army signed a new cooperative agreement with Johns Hopkins University Sept. 30, 2020, to advance materials research using artificial intelligence…
Read More
Alexandria Real Estate Equities, Inc. Achieves the World’s First WELL Health-Safety Rating for Laboratory Space at Alexandria LaunchLabs in New York City
PASADENA, Calif., Nov. 16, 2020 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering…
Read More
Funding Opportunities | MSCRF
We offer six programs to accelerate discovery and commercialization of human stem cell-based technologies. Please verify eligibility, read the appropriate RFA below and apply…
Read More
UK Biotech Companies Thriving in Maryland and Philadelphia Hubs · BioBuzz
For decades, the United States and the United Kingdom have enjoyed a special relationship that crosses political, economic, and military lines. But, the two…
Read More
Announcing the Maryland Future 20 | Maryland Business News
Following a statewide search to identify Maryland’s most innovative start-up companies with the potential to be the state’s next major business success story, Governor…
Read More
OS Therapies Acquires All Indications for OST-HER2 (Listeria monocytogenes) in Solid Tumors, Including Canines
CAMBRIDGE, Md., Nov. 17, 2020 /PRNewswire/ -- OS Therapies, a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat and cure Osteosarcoma (OS)…
Read More
What monoclonal antibodies are – and why we need them as well as a vaccine
When President Trump was diagnosed with COVID-19, one of the cutting-edge experimental therapies he received was a mixture of monoclonal antibodies. But now a…
Read MoreMaryland Today | UMD Ranked in Top 10 for Innovation and Entrepreneurship Education for Sixth Straight Year
For the sixth consecutive year, the University of Maryland (UMD) earned a top 10 ranking in The Princeton Review’s annual survey of top schools…
Read More
SR One Completes Spin-out from GSK and Closes First Fund at $500 Million | Business | thedailytimes.com
SR One, a trans-Atlantic biotech venture capital firm, announced today the close of its first independent fund, having recently completed its spinout from GlaxoSmithKline…
Read More
The state of AI in 2020 | McKinsey
The results of this year’s McKinsey Global Survey on artificial intelligence (AI) suggest that organizations are using AI as a tool for generating value.…
Read More
Protecting Our Future: Spurring Innovation to Support Pediatric Preparedness
With COVID-19, we’ve seen our preparedness response tested, and the question remains, how can we be better prepared to protect some of the most…
Read More
BLUE KNIGHT™ Symposium
In seeking to combat emerging infectious diseases and other 21st century health threats, the path to better prepared, protected, and healthy individuals, families, and…
Read More
Join the Force: An Info Session on JLABS @ Washington, DC and the BLUE KNIGHT™ Collaboration
BLUE KNIGHT™, a collaboration between Johnson & Johnson Innovation – JLABS and the Biomedical Advanced Research and Development Authority (BARDA), offers emerging life science…
Read More
Private S. Korean investments in biohealth to reach 10 trillion won by 2023 – EconoTimes
South Korea’s leading biologics companies will invest hundreds of billions of won to building additional plants that would push the total amount of private…
Read More
Immunomic Therapeutics and CoImmune Therapeutics Enter into Partnership to Manufacture ITI-1020, a Novel Experimental Cell Therapy for Glioblastoma | Business Wire
ROCKVILLE, Md. & DURHAM, N.C.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, and CoImmune,…
Read More